David A. Siegel Amarin Corp Plcuk Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,293,200 shares of AMRN stock, worth $15.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,293,200

Previous 1,739,300 25.65%

Holding current value

$15.3 Million

Previous $834,000 1289.33%

% of portfolio

0.03%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.4 - $8.96 $178,440 - $4 Million	-446,100 Reduced 25.65%	1,293,200 $11.6 Million
Q4 2024 Feb 14, 2025	SELL	$0.44 - $0.63 $104,148 - $149,121	-236,700 Reduced 11.98%	1,739,300 $834,000
Q3 2024 Nov 14, 2024	SELL	$0.57 - $0.8 $349,922 - $491,120	-613,900 Reduced 23.7%	1,976,000 $1.24 Million
Q2 2024 Aug 14, 2024	SELL	$0.63 - $1.07 $140,112 - $237,968	-222,400 Reduced 7.91%	2,589,900 $1.79 Million
Q1 2024 May 15, 2024	BUY	$0.82 - $1.35 $69,452 - $114,342	84,698 Added 3.11%	2,812,300 $2.5 Million
Q4 2023 Feb 14, 2024	SELL	$0.66 - $0.91 $83,371 - $114,952	-126,321 Reduced 4.43%	2,727,602 $2.37 Million
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.43 $344,060 - $578,831	-404,777 Reduced 12.42%	2,853,923 $2.63 Million
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.49 $421,344 - $560,538	376,200 Added 13.05%	3,258,700 $3.88 Million
Q1 2023 May 15, 2023	BUY	$1.19 - $2.19 $1.24 Million - $2.29 Million	1,043,800 Added 56.77%	2,882,500 $4.32 Million
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $1.18 Million - $1.47 Million	1,098,400 Added 148.37%	1,838,700 $2.22 Million
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $478,074 - $732,462	438,600 Added 145.38%	740,300 $807,000
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $169,047 - $552,024	149,600 Added 98.36%	301,700 $450,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $259,882 - $340,127	91,187 Added 149.7%	152,100 $500,000
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $3,781 - $6,045	1,167 Added 1.95%	60,913 $205,000
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $3,546 - $5,256	-900 Reduced 1.48%	59,746 $305,000
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $258,351 - $394,199	60,646 New	60,646 $266,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $1.14 Million - $2 Million	-226,846 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $416,980 - $548,061	103,213 Added 83.48%	226,846 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $244,608 - $521,472	67,200 Added 119.08%	123,633 $520,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $269,749 - $466,136	56,433 New	56,433 $391,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $532,508 - $921,384	-38,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $530,598 - $884,712	38,200 New	38,200 $579,000
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $3.87 Million - $6.85 Million	-306,846 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $3.4 Million - $6.29 Million	-273,767 Reduced 47.15%	306,846 $4.18 Million
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $1.26 Million - $8.38 Million	-514,933 Reduced 47.0%	580,613 $9.45 Million
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $18,224 - $23,664	6,800 Added 0.62%	1,095,546 $3.39 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $360,594 - $535,464	120,600 Added 12.46%	1,088,746 $3.28 Million
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $1.5 Million - $2.01 Million	491,600 Added 103.16%	968,146 $3.88 Million
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $1.44 Million - $1.77 Million	476,546	476,546 $1.67 Million

Others Institutions Holding AMRN

# of Institutions

154

Shares Held

70.1M

Call Options Held

133K

Put Options Held

26.4K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $4.78B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account